Economic Model of First-Line Drug Strategies to Achieve Recommended Glycaemic Control in Newly Diagnosed Type 2 Diabetes Mellitus

This publication has 34 references indexed in Scilit:

• A ???Real-World??? Analysis of Persistence on and Adherence to Glipizide GITS, Glipizide IR and Glibenclamide in Managed Care among Patients with Type 2 Diabetes Mellitus
  Clinical Drug Investigation, 2002
• Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus
  Experimental and Clinical Endocrinology & Diabetes, 2000
• Repaglinide in Type 2 Diabetes: A 24-Week, Fixed-Dose Efficacy and Safety Study
  The Journal of Clinical Pharmacology, 2000
• SULFONYLUREAS
  Endocrinology and Metabolism Clinics of North America, 1997
• Efficacy, Safety, and Dose-Response Characteristics of Glipizide Gastrointestinal Therapeutic System on Glycemic Control and Insulin Secretion in NIDDM: Results of two multicenter, randomized, placebo-controlled clinical trials
  Diabetes Care, 1997
• Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes
  Diabetes, 1996
• Foot Care Assessment in Patients with Diabetes: A Screening Algorithm for Patient Education and Referral
  The Diabetes Educator, 1995
• Antihyperglycaemic Efficacy, Response Prediction and Dose—Response Relations of Treatment with Metformin and Sulphonylurea, Alone and in Primary Combination
  Diabetic Medicine, 1994
• Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled study
  Diabetes Care, 1994
• Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications
  Journal Of Hypertension, 1993